Effects of 5-HT3, D1 and D2 receptor antagonists on ethanol- and cocaine-induced locomotion. (Q51543480)

6 April 2018

title

Effects of 5-HT3, D1 and D2 receptor antagonists on ethanol- and cocaine-induced locomotion. (English)

1 reference

6 April 2018

author

Edward M. Sellers

5

1 reference

6 April 2018

author name string

Lê AD

1

1 reference

6 April 2018

Tomkins D

2

1 reference

6 April 2018

Higgins G

3

1 reference

6 April 2018

Quan B

4

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

6 April 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

6 April 2018

volume

57

1 reference

6 April 2018

issue

1-2

1 reference

6 April 2018

page(s)

325-332

1 reference

6 April 2018

D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Nicotine self-administration and locomotor activity are not modified by the 5-HT3 antagonists ICS 205-930 and MDL 72222.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Biphasic effects of ethanol on open-field activity: sensitivity and tolerance in C57BL/6N and DBA/2N mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Effects of D1 and D2 dopamine receptor agents on ethanol consumption in the high-alcohol-drinking (HAD) line of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Effect of spontaneous ingestion of ethanol on brain dopamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Effect of drugs influencing 5-HT function on ethanol drinking and feeding behaviour in rats: studies using a drinkometer system.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Influence of 5-HT3 receptor antagonists and the indirect 5-HT agonist, dexfenfluramine, on heroin self-administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Specific decreases in ethanol- but not water-reinforced responding produced by the 5-HT3 antagonist ICS 205-930.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c, C57BL/6, and DBA/2 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol consumption in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

The excitatory effect of ethanol: absence in rats, no tolerance and increased sensitivity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Effects of the combined administration of the 5-HT3 antagonist MDL 72222 and ethanol on conditioning in the periadolescent and adult rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Haloperidol reduces ethanol-induced motor activity stimulation but not conditioned place preference.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Effect of Ro 15-4513 on ethanol-induced conditioned place preference

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Attenuation of defensive analgesia in male mice by 5-HT3 receptor antagonists, ICS 205-930, MDL 72222, MDL 73147EF and MDL 72699

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR38032F, on non-opioid defeat analgesia in male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Effect of dopamine agonists and antagonists on ethanol-reinforced behavior: the involvement of the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Does tolerance develop to the activating, as well as the depressant, effects of ethanol?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900333-4

7 January 2021

10.1016/S0091-3057(96)00333-4

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

9164590

1 reference

6 April 2018